**What Is Known**Microbial colonization in early life can affect later health status with preterm infants at greater risk of microbially impacted disease states such as necrotizing enterocolitis and late-onset sepsis.Preterm infants within the neonatal intensive care unit do not face typical colonization exposures.Previous comparative studies show conflicting findings with either individual patient in closer-to-term infants, or sampling site in more preterm infants explaining greatest difference between microbial communities.**What Is New**This study represents the first to characterize microbial acquisition and development exclusively in a cohort of extremely preterm infants born \<24 weeks gestational age.Development of microbial communities in intubated, extremely preterm infants occurs holistically, across all body-sites with longitudinal specialization toward divergent communities.Breast milk and oral and endotracheal microbiota shows decreasing associations with stool communities over time, with oral communities exhibiting greatest impact and substantial environmental influence.

The 24 months after birth represent a period of turbulent microbiota development as neonates transition to a more stable state ([@R1],[@R2]). This turbulence is even more apparent in preterm infants at risk of disease states such as late-onset infection and necrotizing enterocolitis (NEC).

Neonatal exposures essential to preterm infant care impact microbiota development. Exposures include increased time to full milk feeds, parenteral nutrition, administration of antibiotics or antifungals ([@R3]--[@R6]), and use of indwelling medical devices ([@R7]). Extremely preterm infants also have a naïve immune system and intestinal function ([@R8]). All such factors contribute to a proinflammatory state ([@R9]), increasing likelihood of NEC development. In addition, indwelling medical devices increase the likelihood of biofilm formation which may provide a source of persistent, pathogenic, antibiotic resistant bacteria ([@R10]).

Previous studies in more mature infants have identified individual-specific signatures, irrespective of body-site sampling ([@R11],[@R12]). This is in agreement with the findings of the human microbiome project, which included exclusively term infants ([@R13]). Few studies have attempted to identify environmental sources of microbial colonization in preterm infants ([@R14],[@R15]), although results highlight similarities between ward surfaces and infants' microbiota.

Typically, studies have used stool as a proxy for the gut lumen to compare microbiota between delivery modes ([@R16]), and in cases of NEC ([@R17]), and late-onset sepsis (LOS) ([@R18]), increasing our understanding of the gut microbiota in health and disease states. This study explores further the acquisition of the gut microbiota by supplementing stool microbial profiling with identification of exclusively viable bacterial communities in several other sampling sites. These include oral (ORS), and endotracheal (ETS), samples, as well as maternally expressed breast milk (EBM), samples taken from the feeding tubes to generate a more holistic view of microbiota development and track succession of microbiota acquisition throughout the gastrointestinal tract. Our sample salvaging method facilitated use of suctioned samples from these areas, performed as part of routine clinical care. We focused on the most immature infants since they are currently least well represented in the literature and most vulnerable to the preterm associated diseases NEC and LOS. This cohort includes both infants who developed these diseases and those who did not.

METHODS
=======

Sample Collection
-----------------

Longitudinal samples from 4 distinct sites (oral and endotracheal secretions, maternal breast milk from feeding tubes and stool) were collected from a cohort of extremely preterm (\<26 weeks gestational age (GA), at birth), infant-mother dyads (n = 7), meeting the inclusion criteria (Methods, SDC1, Supplemental Digital Content), including 1 twin pair, over the first 60 days of life (figure, SDC2, Supplemental Digital Content). All were cared for simultaneously in the neonatal intensive care unit (NICU), at the Royal Victoria Infirmary, Newcastle upon Tyne, England, ventilated from birth and received breast milk feeds. The NICU employs standardized approaches to nutrition including administration of maximal amounts of maternal EBM progressed at standard rates as far as infant tolerance permits and standardized management of sepsis. Infants routinely received probiotic supplementation consisting of a liquid preparation of *Lactobacillus acidophilus*, *Bifidobacterium bifidum*, and *B infantis* (Labinic, Biofloratech, UK), as soon as minimal enteral nutrition was tolerated (Fig. SDC3, Supplemental Digital Content). Samples were collected under ethical permission granted by NRES Committee North East---Newcastle & North Tyneside 2 (10/H0908/39), and analysed with written parental consent.

Maternal EBM collected from either the nasogastric feeding tube or from residual volume in bottles and syringes was collected into sterile cryovials. Oral and endotracheal secretions were collected in a sterile catheter via routine suction when clinically indicated. Stool samples were collected from the nappy in a sterile glass pot. Sample collections were opportunistic rather than predefined. All samples were stored frozen at −20°C until transfer to −80°C, usually within 7 days, until processing.

Relevant clinical details were collected from each infant\'s medical notes and are displayed in Table [1](#T1){ref-type="table"}. NEC and sepsis were diagnosed and categorized by agreement of senior research clinicians by reviewing clinical, laboratory, x-ray, and operative findings.

###### 

Patient Demographics

                Gestational age   Birth weight   Mode of delivery   DoL full feeds   DoL probiotic start   Breast milk fortifier start (DoL)   Key disease            DoL NEC onset   DoL +ve BC   Antibiotics (DoL administered)   Total days Abx administered   Survival to discharge
  --------- --- ----------------- -------------- ------------------ ---------------- --------------------- ----------------------------------- ---------------------- --------------- ------------ -------------------------------- ----------------------------- -----------------------
  Patient                                                                                                                                                                                                                                                         
            1   24+3              600            Vaginal            11               4                     56                                  Medical NEC            41              \-           0,9,38,40,41                     23                            Yes
            2   25+2              700            Vaginal            14               7                     21                                  \-                     \-              \-           0,4,14,26                        14                            Yes
            3   23+3              520            Vaginal            13               3                     17                                  \-                     \-              \-           0,3,18,41,51                     23                            Yes
            4   23+2              580            Vaginal            10               4                     44                                  Sepsis                 \-              40           0,40                             16                            Yes
            5   23+1              520            Vaginal            50               3                     NR                                  Surgical NEC, sepsis   14 (op18)       23           0,7,14,15,18,25,37,40            38                            No
            6   23+1              590            Vaginal            21               7                     40                                  \-                     \-              \-           0,25,37                          41                            Yes
            7   23+4              500            Caesarean          15               6                     NR                                  Sepsis                 \-              7            0,7,15                           9                             Yes
  Mean          23.4              573                                                                                                                                                                                                                             

Patient demographic data for all 7 patients sampled longitudinally in this study. Averages for continuous variables are expressed as the mean. Abx = antibiotics, BC = Blood culture, DoL = Day of life, +ve = Positive, NEC = Necrotising Enterocolitis, NR = not received, op = operated, dashes used to represent no diagnosed diseases.

Propidium Monoazide Treatment and DNA Extraction
------------------------------------------------

Samples were processed within randomized batches to reduce confounding effects of contaminant DNA. All samples were treated with propidium monoazide to exclude nonviable bacterial cell DNA before extraction of microbial DNA, as previously described ([@R19]). Microbial DNA was extracted from breast milk, oral and endotracheal suction samples using *QIAGEN PowerFood DNA Microbial Isolation Kits* (Hilden, DE), and from stool samples using *QIAGEN PowerLyzer PowerSoil DNA Microbial Isolation Kits*. All DNA extractions were done as per manufacturers' instructions but supplemented with a prolonged bead beating step, to ensure lysis of Gram-positive bacteria.

Library Preparation and Sequencing
----------------------------------

Because of high variability in extracted bacterial DNA yield (figure, SDC4, Supplemental Digital Content), presequencing normalization of sample DNA content was performed by quantitative PCR (Methods, SDC5, Supplemental Digital Content). Following normalization, nested, full-length 16S rRNA gene PCR was performed to maximize nonviable DNA exclusion ([@R19]).

Sequencing libraries were prepared for targeted sequencing of the V4 region of the 16S rRNA gene from PCR amplicons as per the Schloss standard operating procedure (SOP), ([@R20]), using primers 515F and 806R ([@R21]), (table, SDC6, Supplemental Digital Content). Libraries were sequenced on the Illumina MiSeq platform (CA), using V2 (2 × 250), chemistry.

Paired end reads were trimmed, merged, and processed by alignment to the SILVA database, followed by de novo clustering in to operational taxonomic units, and taxonomic assignment in Mothur, following the MiSeq SOP ([@R20]).

Extraction kit and sequencing negative controls were prepared and sequenced simultaneously with all samples (Methods, SDC7, Supplemental Digital Content).

Statistical Analysis
--------------------

To compare microbial community compositions alpha and beta diversity indices (Shannon diversity, weighted Bray-Curtis dissimilarity), were calculated using the *vegan* community ecology package in R ([@R22]). Kruskal-Wallis rank-sum test and pairwise Mann-Whitney-Wilcoxon test were employed to compare means of continuous data. Adonis PERMANOVA was used to identify metadata variables impacting microbiota composition. Multivariate comparisons were performed by pairwise PERMANOVA. To stratify dominant and rare taxa within sampling site communities, distribution abundance relationships were calculated ([@R23]) (methods explained in figure, SDC8, Supplemental Digital Content). Differentially abundant bacteria between anatomical sites were identified by LEfSe. Influence of the microbiota of upstream anatomical sites on that of the stool was performed using *SourceTracker*([@R24]), and linear regressions of bacterial relative abundances. Bonferroni correction was applied during pairwise comparisons across all sites.

RESULTS
=======

Patient Demographics
--------------------

EBM (n = 40), oral secretions (ORS: n = 40), endotracheal secretions (ETS: n = 35), and stool (n = 38), samples were analysed. Both mean birth weight (584 g, standard deviation \[SD\] = 66 g), and mean gestational age (23.6 weeks, SD = 0.8 weeks), were lower than in previous preterm infant microbiota studies ([@R11],[@R15],[@R17],[@R18],[@R25]). Two patients developed NEC, 3 patients developed LOS, and 3 patients developed neither. Patient demographics are described in Table [1](#T1){ref-type="table"}.

Sequence Data Analysis
----------------------

A total of 7.74 × 10^6^ sequence reads from 3109 operational taxonomic units were observed in 153 PMA-treated samples (mean reads per sample = 4.90 × 10^4^, SD = 5.91 × 10^4^). Filtering of any taxa not classified to at least the class level and 86 potential contaminant taxa yielded 6.72 × 10^6^ reads (mean per sample = 4.39 × 10^4^, SD = 4.72 × 10^4^) (table, SDC9, Supplemental Digital Content). Remaining reads were normalized by expression of total counts as relative abundances per sample. Comparisons of results obtained from PMA-treated samples with non-PMA-treated samples are available as supplementary materials (table, SDC10; Figure, SDC11, Supplemental Digital Content).

Stool Microbiota Diverges From Upstream Microbiota Over Time
------------------------------------------------------------

Longitudinal progression of microbiota composition was observed, with multiple shared taxa observed between different patients (Fig. [1](#F1){ref-type="fig"}).

![Longitudinal microbiota development of the top 20 most abundant bacterial taxa across all patients and body sites on a weekly scale. Where multiple samples were collected in the same week relative abundances were summed before rescaling.](jpga-70-12-g001){#F1}

Over the first 60 days of life a general increasing trend in alpha diversity was observed in all upstream sites, but stool diversity decreased over this time (Fig. [2](#F2){ref-type="fig"}A and B). During the first 6 weeks of life all body site microbiota showed similar diversity, but by week of life (WoL) 7 and 8 significant differences were observed in diversity between the breast milk, oral (*P* = 0.05), and stool (*P* = 0.001) communities (table, SDC12, Supplemental Digital Content). Stool microbiota showed significantly lower bacterial alpha diversity than both breast milk and endotracheal communities when all time points were considered (*P* \< 0.05).

![Longitudinal community differences between breast milk (red), oral (blue), endotracheal (green), and stool (purple), microbiota. Stool was significantly less diverse (Shannon diversity), than breast milk (MWW: *P*.adj = 0.009), endotracheal (MWW: *P*.adj = 0.014), and oral (MWW: *P*.adj = 0.024) communities (A), with longitudinally decreasing diversity (B). Potential sources of the stool microbiota, including unknown sources (grey), as calculated by SourceTracker are illustrated longitudinally (C). Beta diversity (Bray-Curtis dissimilarity) between microbiota is illustrated in ordinations (D, E), and explains 74.5% of sample variance. Point size in ordinations depicts week of life. Results of the respective pairwise PERMANOVA are available online (table, SDC13, Supplemental Digital Content). PC = principle component; WoL = week of life.](jpga-70-12-g002){#F2}

At earlier time points the microbiota of upstream sampling sites and stool show much greater similarity (combined similarity with stool: 49% at WoL 1 and 2), than at later time points (combined similarity with stool: 27% at WoL 8) (Fig. [2](#F2){ref-type="fig"}C). Over time stool microbiota showed increasing similarity to previous stools (13% at WoL 2; 57% at WoL 5 and 7). The oral microbiota was the most similar to the stool microbiota, with an average similarity of 26% compared to breast milk (6%), and endotracheal samples (10%). Unknown, likely environmental, sources, also play a substantial role in shaping the stool microbiota, comprising as much as 51% at WoL 1. Established stool microbiota had greater average similarity (32%), than any upstream or unknown sources. The greater similarity of upstream and unknown sources in the immediate neonatal period suggests community plasticity diminishes with time and may have important implications for timing of interventions designed to influence the microbiota.

Substantial overlap of community composition was observed between separate sampling sites (Fig. [2](#F2){ref-type="fig"}D/E). Greatest overlap between site microbiota was observed between breast milk/feeding tube and endotracheal communities, suggesting seeding of the respiratory microbiome by breast milk (Figure SDC14, Supplemental Digital Content).

Adonis PERMANOVA based on Bray-Curtis dissimilarity, identified both sampling site (*R*^2^ = 14%, *P* = 0.001), and day of life (*R*^2^ = 18%, *P* = 0.02), as the main individual factors impacting microbiota dissimilarity (table, SDC10, Supplemental Digital Content). When combined these 2 factors demonstrated the greatest impact on community composition (*R*^2^ = 30%, *P* = 0.04) (table, SDC10, Supplemental Digital Content). Despite small sample sizes, NEC and LOS had an insignificant impact on community composition when stratified by sampling site (*R*^2^ = 1%, *P* = 0.04), suggesting no difference was observed within site microbiota between diseased babies and controls.

Few Dominant Taxa Are Well Dispersed Across All Sampling Sites
--------------------------------------------------------------

Four dominant taxa were shared across all sampling sites: *Escherichia*, *Enterococcus*, *Staphylococcus,* and an unclassified Enterobacteriaceae. These 4 conserved dominant taxa were the only dominant taxa found in the stool microbiota. Significant positive relationships identified between distribution and abundance (*P* \< 0.001), of bacterial taxa enabled classification of all taxa in the upper quantile of occupancy as dominant and all other taxa as rare community members (figure, SDC8, Supplemental Digital Content).

Multiple other taxa were shared between sampling sites (Fig. [1](#F1){ref-type="fig"}), with a *Rhodococcus* spp. identified by both culture and sequencing as dominant in all upstream mucosal sites despite not having been previously associated with such environments.

Homogenizing Effects of Dominant Taxa Masks Differential Influence of Rare Community Members
--------------------------------------------------------------------------------------------

The prevalence and abundance of the 4 dominant taxa within all anatomical sites obscured the divergent impact of the rare taxa within the microbiota. Despite the apparent overlap in microbiota observed by ordination, significant differences between all anatomical site communities were identified by pairwise PERMANOVA (*P*.adj = 0.006 \[table, SDC13, Supplemental Digital Content\]).

Stratification of the microbiota into common and rare communities enabled identification of rare features of the microbiota responsible for the significant dissimilarity observed between anatomical sites. LEfSe analysis (Fig. [3](#F3){ref-type="fig"}), identified proportionally greater Actinobacteria (*P* \< 0.001), specifically the Nocardiaceae (*P* \< 0.001) in breast milk. The *Rhodococcus* spp., already identified as being ubiquitous throughout upstream mucosal samples in this study belongs to the family Nocardiaceae. The absence of *Rhodococcus* from stool microbiota indicates that it is unable to survive passage through either the (acidic) stomach or the hypoxic gut.

![Results of LEfSe analysis, identifying the discriminative rare taxonomic features between the 4 sampling sites investigated (A), and describing the effect size of each discriminative feature (B). The cladogram is rooted at the kingdom level and discriminative features identified following removal of 4 dominant common taxa are coloured by site as described in Figure [2](#F2){ref-type="fig"}. Where space was not available to plot the taxon name on the cladogram (A) a letter was assigned. These correspond to the taxa, as detailed in (B).](jpga-70-12-g003){#F3}

The obligate anaerobic family of Bifidobacteriaceae were observed in significantly greater proportional abundance (*P* \< 0.001) in the anaerobic gut environment than the aerobic environments of the upper sampling sites or breast milk (Fig. [3](#F3){ref-type="fig"}). The greater proportional abundance of Bifidobacteriaceae in the gut may be due to the administration of probiotics to the patients studied here and specialization of the genus for colonization of the human milk oligosaccharide rich, hypoxic environment of the infant gut.

DISCUSSION
==========

The majority of studies in extremely preterm infants explore the relationship between gut microbiota and disease states ([@R17],[@R18]), nosocomial surfaces ([@R14],[@R15],[@R26]), or maternal breast milk ([@R27],[@R28]). None have previously focused exclusively on such an extremely premature infant cohort ([@R11],[@R15],[@R17],[@R18],[@R25],[@R29]). To our knowledge this is the first study to characterize microbial acquisition in a cohort of infants with a mean GA \<24 weeks. This study also represents the first to utilize viability determination to explore holistic gastrointestinal microbiota assembly. We deliberately included both clinically well infants and those with LOS and NEC since up to 1 in 3 of extremely preterm infants will experience these complications of prematurity.

Despite considerable overlap between the gut microbiota and upstream sites, divergence is already apparent within the first 60 days of life. We highlight strong homogenizing influences of 4 dominant taxa, which persist from initial sampling, throughout this study. These results reflect the findings of previous studies ([@R11],[@R12]), which describe ubiquitous communities across preterm anatomical sites, and the Human Microbiome Project, which observed patient-specific microbial signatures in healthy, term infants ([@R13]). In contrast, but in agreement with Costello et al ([@R30]), we observed sitewise and longitudinal differences to be the major determinant of variation between extremely preterm infant microbiota.

The longitudinal sampling performed in this study highlights site microbiota are more similar during early life and diverge over time, thus suggesting bacterial seeding at birth is "body wide," not site specific. Individual site microbial communities then evolve toward adult-like profiles over time. We build upon the work of previous studies by demonstrating the potential of rare members of the microbiota to drive processes of environmental selection, expanding divergence between patient and site microbiota.

This study shows anatomical sites in closer proximity share more similar bacterial communities than those anatomically disparate from one another. Indeed, breast milk and endotracheal microbiota shared the greatest similarity in abundance of individual taxa, whereas the least similarity was observed between the microbiota of breast milk and stool. Transit through the acidic stomach environment may be a factor in the selectivity and limited dispersal from the upstream sites to the lower gut microbiota. This could also explain the greater observed similarity between the sites at earlier time points ([@R31]).

The 4 taxa conserved between all body sites (*Enterococcus,* Enterobacteriaceae, *Staphylococcus*, and *Escherichia)*, were the only dominant taxa identified in the stool by distribution abundance relationship and largely responsible for observed homogenisation between sample microbiota. This may suggest a bi-directional translocation of bacteria between upstream and downstream gastrointestinal environments, potentially contributed to through NICU practices and handling by parents and staff ([@R26]). Moossavi et al ([@R32]) recently demonstrated that indirect breast-feeding may be linked with greater abundance of environmental microbes such as Enterobacteriaceae and Enterococcaceae. Given NICU feeds are all delivered indirectly this provides an explanation for the dominance of such bacteria observed in this study.

The large impact of unknown sources on stool microbiota composition identified here suggests the sampling strategy employed failed to capture all possible influences of the infant gut microbiota. Likely unsampled sources of bacteria are well summarized in a review by Hartz et al ([@R26]), including care givers and their equipment, maternal and paternal skin, and nosocomial surfaces.

Stratification of communities in to common and rare members highlighted several discriminative taxa between sampling site microbiota. More specifically, the Nocardiaceae family exhibited differentially greater relative abundance in breast milk samples. This is of interest because of the prevalence of *Rhodococcus* within the upstream microbiota of all infants despite no previous identification of this.

To our knowledge, *Rhodococcus* has not been previously reported in breast milk, nor is it archived within the Human Oral Microbiome Database. *Rhodococcus* is usually associated with the environment ([@R33],[@R34]), although member species have been identified as potential human pathogens ([@R35]--[@R37]), especially in immunocompromised individuals, with whom immunologically naïve extremely preterm infants may share similar features.

A 737 bp sequence of DNA extracted from isolated colonies cultured from breast milk showed greatest similarity to a type strain of *Rhodococcus quingshengii* via Nucleotide BLAST (Methods, SDC7, Supplemental Digital Content). *Rhodococcus quingshengii* has previously been shown to have azole degrading capacity ([@R38]). Fluconazole is a triazole antifungal agent routinely orally delivered in this NICU for prophylactic prevention of candidiasis ([@R39]). Failure to isolate *Rhodococcus* from the probiotics suggests it is not a contaminant of the probiotic supplements. Instead, isolation from breast milk fed to these infants through in situ feeding tubes highlights the need for further studies to explore links between *Rhodococcus*, antifungal prophylaxis, and use of in-situ feeding tubes in preterm infants.

As with any observational study there exist several limitations to these findings. Firstly, patient numbers are relatively small. This is due to the high rates of morbidity and mortality of such an extremely premature infant cohort (mean GA = 23.4 weeks; mean BW = 576 g), which restricted the number of patients able to provide sufficient samples to fulfil the inclusion criteria. In addition, the opportunistic sampling employed restricts the power of comparisons regarding longitudinal microbiota development. Systematic sampling may facilitate further insights in future studies.

Importantly, this study represents the first to exclusively characterize such an extremely preterm population. Although nuances of care and individual circumstances dictate there may not be a "typical" infant born \<24 weeks GA, we demonstrate within individual hospital wards there may be a typical pattern of colonization, characterized initially by few dominant bacterial genera and temporally developing dissimilarity driven by rare community members.

Larger cohort studies would help validate and further explore these findings. Inclusion of neonates from multiple NICUs, exposed to different clinical approaches, such as different approaches to probiotic and nutritional care may substantially impact the results and should be explored further. Greater sequencing resolution may also elucidate directionality of microbial transfer. Access to resected gut lumen tissue would enable further validation of the "multiple-site" hypothesis. All these form part of our ongoing programme of work.

The gestational age and longitudinal sampling of infants in this study are unique in the current literature, despite extremely preterm infants being the most sick and complex. This study demonstrates several associations between the microbiota of stool and multiple upstream mucosal and other environmental communities within the first 60 days of life. Given the importance of dysbiosis in health and disease of extremely preterm infants better understanding of microbial acquisition and development arising from standard NICU exposures and practices may be of clinical benefit.
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